TROW icon

T Rowe Price

113.80 USD
+0.59
0.52%
At close Jan 21, 4:00 PM EST
After hours
113.80
+0.00
0.00%
1 day
0.52%
5 days
2.52%
1 month
-1.96%
3 months
-0.18%
6 months
-1.87%
Year to date
0.33%
1 year
2.86%
5 years
-13.98%
10 years
40.13%
 

About: T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load us and international stock, hybrid, bond, and money market funds. At the end of August 2024, the firm had $1.612 trillion in managed assets, composed of equity (51%), balanced (34%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a us-based asset manager, deriving less than 10% of its AUM from overseas.

Employees: 8,104

0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 8 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

3% more repeat investments, than reductions

Existing positions increased: 395 | Existing positions reduced: 384

1% more first-time investments, than exits

New positions opened: 93 | Existing positions closed: 92

0.63% more ownership

Funds ownership: 74.25% [Q2] → 74.87% (+0.63%) [Q3]

3% less call options, than puts

Call options by funds: $272M | Put options by funds: $282M

2% less funds holding

Funds holding: 1,052 [Q2] → 1,034 (-18) [Q3]

6% less capital invested

Capital invested by funds: $19.1B [Q2] → $18B (-$1.09B) [Q3]

11% less funds holding in top 10

Funds holding in top 10: 9 [Q2] → 8 (-1) [Q3]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$111
2%
downside
Avg. target
$117
3%
upside
High target
$132
16%
upside

8 analyst ratings

positive
0%
neutral
75%
negative
25%
Barclays
Benjamin Budish
78% 1-year accuracy
90 / 115 met price target
1%downside
$113
Underweight
Maintained
17 Jan 2025
Wells Fargo
Michael Brown
74% 1-year accuracy
32 / 43 met price target
4%upside
$118
Equal-Weight
Maintained
14 Jan 2025
Keefe, Bruyette & Woods
Aidan Hall
93% 1-year accuracy
13 / 14 met price target
2%downside
$111
Market Perform
Maintained
13 Jan 2025
Morgan Stanley
Michael Cyprys
83% 1-year accuracy
24 / 29 met price target
16%upside
$132
Equal-Weight
Maintained
20 Dec 2024
Deutsche Bank
Brian Bedell
79% 1-year accuracy
34 / 43 met price target
5%upside
$120
Hold
Maintained
11 Nov 2024

Financial journalist opinion

Based on 10 articles about TROW published over the past 30 days

Positive
Zacks Investment Research
4 days ago
Why T. Rowe Price (TROW) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why T. Rowe Price (TROW) is a Top Value Stock for the Long-Term
Neutral
Zacks Investment Research
1 week ago
T. Rowe Price (TROW) Stock Dips While Market Gains: Key Facts
T. Rowe Price (TROW) closed the most recent trading day at $112.84, moving -0.25% from the previous trading session.
T. Rowe Price (TROW) Stock Dips While Market Gains: Key Facts
Positive
Zacks Investment Research
1 week ago
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
Positive
Seeking Alpha
2 weeks ago
Buy 1 January S&P 500 Dividend Aristocrat Out Of 38 'Safer'
**Investment Thesis:** January's top-yielding Aristocrats include Franklin Resources, Realty Income, Amcor, Kenvue, and Hormel, offering dividends from $1K investments exceeding single share prices. **Rating Justification:** Six more Aristocrats could meet the ideal dividend-to-price ratio with a 45.4% market downturn, making them fair-priced investment opportunities. **Analyst Projections:** Top-ten Aristocrats are expected to deliver 22% to 33.36% net gains by January 2025, with an average net gain of 24.96%.
Buy 1 January S&P 500 Dividend Aristocrat Out Of 38 'Safer'
Neutral
Seeking Alpha
2 weeks ago
Stock Picks From Seeking Alpha's December 2024 New Analysts
In December, we welcomed 29 new analysts to Seeking Alpha and in this article we are showcasing their stock picks and investment strategies. Five buy picks are highlighted on Viasat, Newmont, NeuroOne Medical, X-Fab Silicon Foundries, and ArcerlorMittal. Analysts' recommendations range from Strong Buy to Strong Sell, covering diverse sectors such as healthcare, technology, energy, and consumer goods.
Stock Picks From Seeking Alpha's December 2024 New Analysts
Positive
Zacks Investment Research
2 weeks ago
Why T. Rowe (TROW) Could Beat Earnings Estimates Again
T. Rowe (TROW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why T. Rowe (TROW) Could Beat Earnings Estimates Again
Neutral
Seeking Alpha
3 weeks ago
My Best Dividend Aristocrats For January 2025
The ProShares S&P 500 Dividend Aristocrat ETF rocked a cool 4.85% gain in November, but it's giving up nearly half of its return this year in December. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 41 months of tracking these strategies, two strategies are generating a CAGR superior to NOBL.
My Best Dividend Aristocrats For January 2025
Positive
Seeking Alpha
3 weeks ago
These 5 Stocks Are My Top Picks For 2025
In this article, I am listing my top picks for a successful investing year 2025. Every company on this list has a very high quality business model and is operating in a growing market. Providing the growth catalyst of each company, the main risk and potential undervaluation ranging from 13% to 26%.
These 5 Stocks Are My Top Picks For 2025
Positive
Zacks Investment Research
3 weeks ago
5 Reasons Why You Should Invest in T. Rowe Price Stock Right Now
TROW's solid AUM balance and organic growth look encouraging. Its impressive capital distribution moves are added advantages.
5 Reasons Why You Should Invest in T. Rowe Price Stock Right Now
Neutral
Zacks Investment Research
4 weeks ago
TROW vs. ARES: Which Stock Is the Better Value Option?
Investors looking for stocks in the Financial - Investment Management sector might want to consider either T. Rowe Price (TROW) or Ares Management (ARES).
TROW vs. ARES: Which Stock Is the Better Value Option?
Charts implemented using Lightweight Charts™